Meta-analysis finds invasive therapy reduces MI and revascularization in elderly NSTEMI patients
Older Heart Attack Patients Do Better With Stents But Face Bleeding Risks
This systematic review and meta-analysis of 2997 elderly patients with NSTEMI found that invasive therapies, compared with medical therapy, …
New data shows stents help older heart attack patients avoid repeat events but do not lower overall death rates compared to medicine alone.
ALBI score predicts mortality risk in patients with non-ST-segment elevation myocardial infarction
ALBI Score Predicts Heart Attack Survival Risk
This retrospective cohort study of 982 patients with non-ST-segment elevation myocardial infarction (NSTEMI) evaluated the albumin-bilirubin…
This simple liver test may help predict which heart attack patients face the highest risk after leaving the hospital.
Residual global μQFR assessment associated with 3-year MACE risk in acute coronary syndrome patients
Better Heart Maps Predict Long-Term Survival
This post hoc analysis of a randomized controlled trial evaluated 2,428 acute coronary syndrome patients over 36.0 months.
A new heart map predicts long-term survival just as well as expensive pressure wires, helping doctors spot high-risk patients after stent pr…
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
SGLT2 inhibitors and GLP-1 receptor agonists show similar MACE reduction in type 2 diabetes
Trial shows similar heart benefits for two diabetes medications
This systematic review and network meta-analysis compared SGLT2 inhibitors and GLP-1 receptor agonists for major adverse cardiovascular even…
Two common types of diabetes drugs both show significant reductions in major heart events for patients with a history of heart attacks.
Behavioral and metabolic factors characterize a distinct premature atherosclerosis phenotype in Chinese patients
Smoking and Metabolic Factors Linked to Heart Attacks in China
This systematic review of 317 observational studies maps risk factors for premature myocardial infarction (PMI) in China. The synthesis iden…
A large review of 317 studies identifies specific behavioral and metabolic risk factors for heart attacks among Chinese patients.
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Percutaneous transcatheter closure using an Amplatzer Muscular VSD Occluder treats left ventricular pseudoaneurysm
Transcatheter Closure Shows Promise for Heart Failure Patients
This case report describes a 75-year-old male with heart failure and a left ventricular pseudoaneurysm successfully treated via percutaneous…
A new procedure using a transcatheter occluder may offer a safe way to treat heart failure caused by a specific heart wall defect.
Magnetocardiography identifies infarction features in MINOCA patients with normal ECG findings
Magnetocardiography shows heart damage when standard tests are normal
This case series explores the use of magnetocardiography (MCG) for identifying myocardial infarction in patients with non-ST-segment elevati…
New imaging may help identify heart attacks in patients whose standard EKG results appear normal, offering a potential new tool for clearer …
21% hypertension prevalence in transgender adults: meta-analysis of cardiovascular morbidities
Transgender adults face high rates of heart disease
This meta-analysis of observational studies reports pooled prevalence of major cardiovascular morbidities among transgender adults aged ≥18 …
One in five transgender adults has high blood pressure, and many have heart disease, a new analysis finds.
Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
Trial shows microaxial flow pump does not reduce heart damage
This randomized controlled trial of 527 adults with acute anterior STEMI found that LV unloading with a transvalvular microaxial flow pump f…
A clinical trial found that using a transvalvular microaxial flow pump before heart surgery did not reduce the size of heart tissue damage.
Macrophage migration inhibitory factor serves as a potential biomarker and therapeutic target for atrial fibrillation
Protein levels may predict heart failure and stroke risks
This systematic review synthesizes evidence regarding macrophage migration inhibitory factor (MIF) in the context of atrial fibrillation and…
A specific protein called MIF is linked to heart damage and can help doctors predict serious complications like stroke or heart failure.
Finerenone reduces mortality and heart failure risk (HR 0.644) in post-AMI patients
Finerenone may lower heart failure risk after heart attack
This retrospective cohort study of 1,012 adult patients with AMI found that finerenone initiation within 6 months was associated with a lowe…
A new look at real-world data suggests the drug finerenone could protect hearts and kidneys in patients following a heart attack.
Immune-stromal imbalance drives heart failure after myocardial infarction, systematic review finds
Immune cell balance determines if heart tissue heals or fails
This systematic review maps the bidirectional regulatory network between immune cells and cardiac stromal cells after myocardial infarction.…
A new map of how immune cells talk to heart tissue helps explain why some hearts heal after a heart attack while others develop failure.
Tocilizumab shows early anti-inflammatory effects but no significant clinical benefit in STEMI or NSTEMI
Tocilizumab shows early signs of heart protection in heart attacks
This meta-analysis of randomized controlled trials evaluated tocilizumab for patients with STEMI and NSTEMI. While the intervention showed a…
A new review looks at how the drug tocilizumab affects patients with heart attacks, showing some early signs of reduced inflammation.
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Questions about non-ST-segment elevation myocardial infarction
Can the ALBI score predict how long I might live after NSTEMI?
Yes, the ALBI score can predict mortality risk after NSTEMI, with higher scores indicating a significantly higher risk of death.
Full answer →